Loss-of-function mutations in the gene encoding GLUT10 are responsible for arterial tortuosity syndrome (ATS), a rare connective tissue disorder. In the present study GLUT10 mediated dehydroascorbic acid (DAA) transport was investigated, supposing its involvement in the pathomechanism. GLUT10 protein produced by in vitro translation and incorporated into liposomes efficiently transported DAA. Silencing of GLUT10 decreased DAA transport in immortalized human fibroblasts whose plasma membrane was selectively permeabilized. Similarly, the transport of DAA through endomembranes was markedly reduced in fibroblasts from ATS patients. Re-expression of GLUT10 in patients' fibroblasts restored DAA transport activity. The present results demonstrate that GLUT10 is a DAA transporter and DAA transport is diminished in the endomembranes of fibroblasts from ATS patients. 
The clinical phenotype also includes aneurysms of large arteries and stenosis of the pulmonary artery. Patients usually present dysmorphic facial features and other connective tissue abnormalities such as hyperextensible skin and joint laxity [2] [3] [4] [5] .
Histopathological analysis shows extreme disorganization and fragmentation of elastic fibers in the arterial wall [2] . SLC2A10 has been localized to human chromosome 20q12-q13.1, one of the genomic loci associated with non-insulin-dependent-diabetesmellitus (NIDDM), thus SLC2A10 has previously been considered as a candidate gene for NIDDM [6] . However, independent studies have failed in confirming any association between SLC2A10 mutations and NIDDM [7] [8] [9] . Three mechanisms have been proposed to explain the link between defective GLUT10 activity and the arterial defects described in ATS.
The first hypothesis, based on the perinuclear localization of GLUT10 in human fibroblasts, assumes that the glucose-dependent regulation of gene expression is altered in ATS. In particular, since in ATS cells the expression of decorin, a known proteoglycan TGFβ signaling inhibitor, was found down-regulated [2] , it was supposed that the glucose-induced upregulation of decorin is missing in ATS, also explaining the upregulation of the TGFβ pathway observed in ATS cells [2] .
The second theory suggests that GLUT10 is involved in transport of dehydroascorbic acid (DAA), the oxidized form of the potent antioxidant ascorbic acid (AA) across the mitochondrial membranes, where GLUT10 has been localized with immunofluorescence studies in smooth muscle cells and adipocytes [10] . Upon being transported into mitochondrial matrix, DAA is reduced to AA, which can eliminate reactive oxygen species (ROS), thereby protecting the cell from oxidative stress. The ROS levels in the aortic smooth muscle cells of GLUT10 knock-out mice [10] are indeed higher under oxidative stress conditions and their mitochondrial DAA transport activity is reduced. However, the relevance of these findings can be questioned as the phenotype of the GLUT10 knockout mice is very mild [11] or even normal [12] as compared to the human ATS phenotype.
A third hypothesis, based on our previous works [13] [14] [15] has also been proposed [16] .
According to this hypothesis, GLUT10 acts as a DAA transporter in the endoplasmic reticulum (ER) membrane. DAA, in turn, is reduced to AA in the ER lumen, where it acts as a cofactor for the hydroxylation of prolyl and lysyl residues by Fe 2+ /2-oxoglutarate dependent dioxygenases, a biochemical reaction crucial for collagen and elastin maturation and folding. Supporting the hypothesis, it was shown that transiently transfected GLUT10-GFP constructs and organelle-specific fluorescent probe ERTracker Blue-White colocalized in rat aortic smooth muscle cells [16] . However, transport activities have not been demonstrated in the ER and other subcellular compartments.
As we demonstrated earlier, DAA is imported into the microsomal lumen by a transport system sharing the inhibitory properties of GLUTs [13] and DAA-derived AA accumulates in the ER lumen [14, 15, 17] . The transport activity was present in liver microsomes [13] , but also in microsomes from various non-hepatic tissues/cells, including human fibroblasts [15] .
Up to now, glucose or DAA transporters have not been molecularly characterized in the endomembranes. The presence of a glucose transporter has long been supposed as a component of the glucose-6-phosphatase system of the ER [18] . This assumption was experimentally confirmed by using genetically encoded fluorescence resonance energy transfer nanosensors [19] . Glucose transport was shown to be mediated by at least two transporters with different characteristics in rat liver microsomes [20] . A possible explanation for this heterogeneity is that various plasma membrane GLUT transporters function locally during ER-to-plasma membrane transit [21] . Transport of DAA is typically mediated by GLUT transporters both in the plasma membrane and endomembranes [22] . Therefore, DAA transport in the ER can be also mediated by a To date, there is no consensus regarding the subcellular localization of GLUT10 and the ligand it transports. On the other hand, GLUT10 could excellently act the part of the missing glucose/DAA transporter of the ER. Therefore, the aim of the present study was to verify the role of GLUT10 as a DAA transporter. Our observations demonstrate that GLUT10 is functioning as a DAA transporter and DAA transport activity is diminished in the endomembranes of fibroblasts from ATS patients lacking functional GLUT10
transporter.
Materials and Methods

Patients and cell cultures
Skin fibroblasts from ATS patients and unrelated healthy donors were established from skin biopsies as previously reported [2] . Patient 1 (P1) was homozygous for the c.1334delG microdeletion [2] ; patient 2 (P2) was compound heterozygous for the c.1309G>A and the c.1330C>T transitions [23] , patient 3 (P3) was homozygous for the c.1411+1G>A splicing mutation [24] ; and patients 4-8 (P4-P8), members of the same family, all bearing the homozygous c.510G>A mutation [2] . Written informed consent was obtained from each patient for skin biopsy procedure. This study was approved by the medical ethical committee of the University Hospital Spedali Civili of Brescia, Italy (in case of P1-P3) and by the Ghent University Hospital, Belgium (for P4-P8), and was performed in accordance with the Declaration of Helsinki Principles.
Dermal fibroblasts cultures were grown in vitro at 37° C in a 5% CO 2 
Indirect immunofluorescence analysis
To analyze the presence and distribution of GLUT10, control, untransfected and mock- Diluted and undiluted samples were then analyzed in duplicate. Amplification efficiency was calculated as reported [27] . The amplification efficiency was more than 90%. Every assay was run in triplicate and negative controls (no template, template produced with no reverse transcriptase enzyme) were always included. In the negative controls, no signal was detected in the investigated amplification range (40 cycles).
Western blot analysis
For Western blot analysis, hTERT cells were subcultured in 6 well plate, and used after 2-3 d. Confluent wells were washed with PBS and lysed with RIPA buffer (50 mM Tris-Cl, pH8, 150 mM NaCl, 1% NP40, 0,1% SDS). Total protein concentration was determined by Pierce BCA Protein Assay Kit (Thermo Scientific, Rockford, Illinois, USA). Equal protein amounts (15-20 µg) were subjected to 10-12% SDS-PAGE and transferred to PVDF membranes by semidry Western blotting. The membranes were blocked in 5% milk or 5% BSA overnight, then probed using specific rabbit polyclonal anti-glucose transporter GLUT10 antibody (1:1000; Abcam, Cambridge, UK) and GAPDH (1:7500; Santa Cruz Biotechnology, Inc., Dallas, Texas, USA). The Western blots were developed using chemiluminescent detection system (Thermo Scientific).
Protein levels were evaluated through densitometry.
Preparation of cells for transport measurements
Cells grown in 75 cm 2 cell culture flasks, were detached by trypsinization, harvested by centrifugation (5 min; 1300 rpm), washed, recentrifuged and resuspended in sterile PBS (2x10 6 cells/ml). The batch-wise translation mixture contained 5 µl wheat germ extract (Cell Free Sciences), 1 µg mRNA, 5 µl liposome (20 mg/ml), 0.8 µl creatine kinase (1 mg/ml) and was completed to 25 µl final volume with 1x SUB-AMIX solution [29] . The reaction was incubated at room temperature for 3 h. The control reactions were set up either without liposome or exogenous mRNA. The reaction mixtures were centrifuged at 13000 rpm for 30 min and both the supernatant and the pellet were analyzed by Western blot. It was observed that the presence of liposomes resulted in more effective translation and less aggregation of GLUT10 protein.
Transport assays
The uptake/transport of DAA, AA and other compounds was investigated by a rapid filtration method with trace amount of radiolabeled compounds as described previously [13] . Intact and plasma membrane-permeabilized cells incubated in the presence of the indicated ligands and their radiolabeled analoges for the indicated times were filtered through glass fiber paper GF/C; 2,5 cm; pore size 0.45 µm (Whatman International Ltd.; Maidstone, Kent, UK). Filters were washed with 2 ml of the medium and the radioactivity retained on the filter was measured by liquid scintillation counting. In each experiment, deoxycholate (0.4% final concentration) was added at the end of the incubations; the radioactivity not released by this maneuver was regarded as binding and was subtracted from the measured values.
Transport into microsomes and proteoliposomes was measured by the same method as described in details earlier [13] . Since the yield of microsomal fraction was poor from Vitamin C content of the medium was determined with the same method.
Results
GLUT10 is a DAA transporter
In the first set of experiments, DAA transport was measured in GLUT10 containing proteoliposomes. GLUT10 protein was produced in an in vitro translational system and the protein was incorporated into liposomes to exclude the eventual indirect effects of the lack of GLUT10 on DAA transport. The presence of GLUT10 in the proteoliposomes was checked by immunoblotting (data not shown). GLUT10- (Fig. 1A) . Glucose transport was also measurable, while unrelated compounds such as UDP-glucuronic acid and sucrose were not transported. A very low AA uptake was also observed, which was presumably due to the oxidation of AA to DAA during the incubation [14] . Incorporation of microsomal proteins prepared from human control fibroblasts into liposomes also promoted the transport of DAA (Fig. 1B) . Protein-free liposomes did not show transport activities (Fig. 1A) .
Silencing of GLUT10 compromises DAA transport
To demonstrate the involvement of GLUT10 in subcellular DAA transport, a hTERT immortalized human fibroblast cell line was silenced for GLUT10 with lentiviral-based silencing vectors. Stable clones expressing the silencing vector were selected and were checked for the efficiency of silencing. Semi-quantitative RT-PCR analysis of the stable clones showed that two silencing constructs out of three were effective ( Fig. 2A) .
Immunoblotting of cell homogenates revealed that only one of the constructs decreased effectively GLUT10 at protein level (Fig. 2B) . Measurement of DAA transport on plasma membrane permeabilized hTERT immortalized human fibroblasts showed that it was severely decreased in these efficiently silenced cells (Fig. 2C) . Strict correlation (R 2 values between 0.8859 and 0.9967) was observed when DAA transport activities were plotted against GLUT10 protein levels detected by Western blot in silenced fibroblasts (Fig. 2D) .
DAA transport through endomembranes is defective in ATS
The uptake of DAA and its reduced form AA was investigated in intact human fibroblasts from healthy controls and ATS patients. Decreased DAA (Fig. 3A) and unchanged AA transport (Fig. 3B) was observed in the patients' fibroblasts, indicating a DAA-specific failure of vitamin C transport. Investigation of long-term AA uptake and accumulation in the presence of physiological AA concentration (50 µM) revealed that the steady-state intracellular concentration of AA was set up at a lower level in patients' fibroblasts comparing with the controls (Fig. 3C) .
To estimate the transport through endomembranes, the plasma membrane of the cells was selectively permeabilized. An even more dramatic decrease in DAA transport was found in cells from ATS patients under this condition, which indicated that the failure is due to a transporter resident in the endomembranes (Fig. 3D) . AA transport was similar in permeabilized control and patient fibroblasts (Fig. 3E ).
Re-expression of GLUT10 in ATS fibroblasts restores DAA transport GLUT10 expression vector (pG10) and empty cloning vector (mock) were stably transfected in the skin fibroblasts of an ATS patient (P1). P1 was intentionally used in the reexpression experiments to avoid any interference with an eventual mutated protein present in the ATS fibroblasts, since the almost complete lack of GLUT10 mRNA, due to activation of nonsense-mediated mRNA decay. These transfected cells do not only reexpress GLUT10, but also rescue a control-like phenotype concerning the extracellular matrix homeostasis and GLUT10-dependent canonical signal transduction mechanisms, as shown in [25] . Absence of the immunoreactivity of GLUT10 was observed in non-transfected (Fig. 4B ) and mock-transfected (Fig. 4C) cells. Reexpression of GLUT10 in patients' fibroblasts resulted in the appearance of GLUT10 immunoreactivity as revealed by immunocytofluorescence ( Fig. 4D ; for comparison see control fibroblasts, Fig. 4A ). Re-expression also restored the impaired DAA transport activity in plasma membrane permeabilized cells (Fig. 4E ). The finding that GLUT10 acts as a DAA transporter is supported by some previous observations. The human phenotype of ATS could not be reproduced in GLUT10 mutant mice, as these mice showed minimal or no pathological signs [11, 12] . The absence of a relevant phenotype in mice could be explained by the fact that mice, in contrast to humans, possess gulonolactone oxidase activity. Thus, mice are able to synthesize AA, independently of dietary intake.
Discussion
It may be hypothesized that in AA-synthesizing species an enhanced AA production can compensate somehow for the reduced activity of organellar AA/DAA transporters. This hypothesis is reinforced by the relevant cardiovascular abnormalities that have been identified in a zebrafish ATS model [31] . This and other teleost species, like humans, lack a functional gulonolactone oxidase gene.
A glucose transporter in the endomembranes, especially in the ER has long been hypothesized as a component of the ER-localized glucose-6-phosphatase system [18] .
The presence of GLUT10 in the endomembranes as a DAA and glucose transporter can be the molecular background of the functionally already observed transport activities [19, 20, 32] . However, it is probable that GLUT10 is not a single DAA/glucose transporter in the endomembranes. Functional studies indicated the heterogeneity of glucose transport in the ER [19, 20] . Moreover, it was also demonstrated that various GLUT transporters can sufficiently mediate glucose transport en route from the ER to the plasma membrane [21] . These circumstances may provide an explanation for the fact that GLUT10 deficiency does not affect similarly all cell types.
The question arises: which function of DAA/AA is missing in the secretory compartment and/or nucleoplasm in ATS patients? Besides the general antioxidant role, AA acts also as a cofactor for 2-oxoglutarate/Fe 2+ dependent dioxygenases [33] . pG10-transfected ATS fibroblasts. DAA (1 mM) transport activity could be measured in plasma membrane permeabilized, GLUT10 re-expressing cells (panel E; empty circles, means ± SEM of three experiments). In panel E, the DAA uptake in permeabilized ATS fibroblasts, shown in Figure 3D , is also reported for comparison (black circles). 
